Alley Investment Management Company’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.1M Sell
107,568
-4,711
-4% -$1.01M 3.16% 5
2026
Q1
$24.4M Buy
112,279
+32
+0% +$7.1K 2.97% 7
2025
Q4
$25.6M Sell
112,247
-6,845
-6% -$1.56M 3% 6
2025
Q3
$27.6M Buy
119,092
+1,373
+1% +$280K 3.2% 6
2025
Q2
$21.9M Buy
117,719
+1,156
+1% +$215K 2.64% 8
2025
Q1
$24.4M Sell
116,563
-1,235
-1% -$240K 3.06% 6
2024
Q4
$20.9M Buy
117,798
+2,951
+3% +$543K 2.65% 8
2024
Q3
$22.7M Buy
114,847
+610
+0.5% +$114K 2.87% 5
2024
Q2
$19.6M Buy
114,237
+411
+0.4% +$68.1K 2.68% 6
2024
Q1
$20.7M Sell
113,826
-1,618
-1% -$279K 2.85% 5
2023
Q4
$17.9M Sell
115,444
-1,120
-1% -$163K 2.61% 10
2023
Q3
$17.4M Buy
116,564
+444
+0.4% +$65.2K 2.95% 6
2023
Q2
$15.6M Sell
116,120
-447
-0.4% -$65.5K 2.52% 8
2023
Q1
$18.6M Buy
116,567
+2,114
+2% +$323K 3.1% 2
2022
Q4
$18.5M Sell
114,453
-178
-0.2% -$27.3K 3.18% 1
2022
Q3
$15.4M Buy
114,631
+3
+0% +$430 3.07% 3
2022
Q2
$17.6M Sell
114,628
-230
-0.2% -$35.1K 3.31% 2
2022
Q1
$18.6M Buy
+114,858
New +$16.7M 3.07% 5

Other funds holding ABBV

Alley Investment Management Company's ABBV Position: Q2 2026 in Review

Alley Investment Management Company reduced its AbbVie (ABBV) stake by 4.2% in Q2 2026, selling an estimated $1.01M and leaving 107,568 shares worth $27.1M. The position accounts for 3.16% of the portfolio, ranked #5.

Alley Investment Management Company first reported a position in ABBV in Q1 2022 and has held it in 18 quarters since. The position peaked at $27.6M in Q3 2025. 3,252 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Alley Investment Management Company held 107,568 shares of AbbVie worth $27.1M as of Q2 2026.
  • Alley Investment Management Company sold 4,711 AbbVie shares in Q2 2026, an estimated $1.01M.
  • AbbVie made up 3.16% of Alley Investment Management Company's portfolio in Q2 2026, its #5 holding.
  • Alley Investment Management Company first reported a position in AbbVie in Q1 2022 and has held it in 18 quarters since.
  • Alley Investment Management Company's AbbVie position peaked at $27.6M in Q3 2025.
  • 3,252 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Alley Investment Management Company's 13F filing for Q2 2026, filed 23 Jul 2026.